123 related articles for article (PubMed ID: 27543977)
21. Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis.
Nakayamada S; Kubo S; Iwata S; Tanaka Y
BioDrugs; 2016 Oct; 30(5):407-419. PubMed ID: 27577235
[TBL] [Abstract][Full Text] [Related]
22. Image-guided radiotherapy for prostate cancer with cone beam CT: dosimetric effects of imaging frequency and PTV margin.
Ariyaratne H; Chesham H; Pettingell J; Alonzi R
Radiother Oncol; 2016 Oct; 121(1):103-108. PubMed ID: 27576431
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks.
Zingler G; Hermann B; Fischer T; Herdegen T
Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1479-1492. PubMed ID: 27575590
[TBL] [Abstract][Full Text] [Related]
24. Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial.
Hattersley G; Harris AG; Simon JA; Constantine GD
Menopause; 2017 Jan; 24(1):92-99. PubMed ID: 27575546
[TBL] [Abstract][Full Text] [Related]
25. Renal Function after Fenestrated or Branched Endovascular Aortic Repair: The Early Impairment Predictive Factors.
de Lachomette MF; Della N; Maucort-Boulch D; Duprey A; Rosset E; Feugier P; Lermusiaux P; Albertini JN; Millon A
Ann Vasc Surg; 2017 Apr; 40():1-9. PubMed ID: 27575304
[TBL] [Abstract][Full Text] [Related]
26. A Systematic Review and Meta-Analysis of Functional Outcomes and Complications Following the Photoselective Vaporization of the Prostate and Monopolar Transurethral Resection of the Prostate.
Kang DH; Cho KS; Ham WS; Choi YD; Lee JY
World J Mens Health; 2016 Aug; 34(2):110-22. PubMed ID: 27574594
[TBL] [Abstract][Full Text] [Related]
27. Managing anesthesia for cesarean section in obese patients: current perspectives.
Lamon AM; Habib AS
Local Reg Anesth; 2016; 9():45-57. PubMed ID: 27574464
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of alirocumab in high cardiovascular risk populations with or without heterozygous familial hypercholesterolemia: Pooled analysis of eight ODYSSEY Phase 3 clinical program trials.
Farnier M; Gaudet D; Valcheva V; Minini P; Miller K; Cariou B
Int J Cardiol; 2016 Nov; 223():750-757. PubMed ID: 27573600
[TBL] [Abstract][Full Text] [Related]
29. A double-blind randomized comparative study of triamcinolone hexacetonide and dexamethasone intra-articular injection for the treatment of knee joint arthritis in rheumatoid arthritis.
Hajialilo M; Ghorbanihaghjo A; Valaee L; Kolahi S; Rashtchizadeh N; Amirkhiz MB; Malekmahdavi I; Khabbazi A
Clin Rheumatol; 2016 Dec; 35(12):2887-2891. PubMed ID: 27572327
[TBL] [Abstract][Full Text] [Related]
30. Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial.
Moriarty PM; Parhofer KG; Babirak SP; Cornier MA; Duell PB; Hohenstein B; Leebmann J; Ramlow W; Schettler V; Simha V; Steinhagen-Thiessen E; Thompson PD; Vogt A; von Stritzky B; Du Y; Manvelian G
Eur Heart J; 2016 Dec; 37(48):3588-3595. PubMed ID: 27572070
[TBL] [Abstract][Full Text] [Related]
31. Endometriosis-associated Maternal Pregnancy Complications - Case Report and Literature Review.
Petresin J; Wolf J; Emir S; Müller A; Boosz AS
Geburtshilfe Frauenheilkd; 2016 Aug; 76(8):902-905. PubMed ID: 27570252
[TBL] [Abstract][Full Text] [Related]
32. Genomic stratification by expression of HLA-DRB4 alleles identifies differential innate and adaptive immune transcriptional patterns - A strategy to detect predictors of methotrexate response in early rheumatoid arthritis.
Stuhlmüller B; Mans K; Tandon N; Bonin MO; Smiljanovic B; Sörensen TA; Schendel P; Martus P; Listing J; Detert J; Backhaus M; Neumann T; Winchester RJ; Burmester GR; Häupl T
Clin Immunol; 2016 Oct; 171():50-61. PubMed ID: 27570220
[TBL] [Abstract][Full Text] [Related]
33. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Cohen H; Hunt BJ; Efthymiou M; Arachchillage DR; Mackie IJ; Clawson S; Sylvestre Y; Machin SJ; Bertolaccini ML; Ruiz-Castellano M; Muirhead N; Doré CJ; Khamashta M; Isenberg DA;
Lancet Haematol; 2016 Sep; 3(9):e426-36. PubMed ID: 27570089
[TBL] [Abstract][Full Text] [Related]
34. HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology.
Schache AG; Powell NG; Cuschieri KS; Robinson M; Leary S; Mehanna H; Rapozo D; Long A; Cubie H; Junor E; Monaghan H; Harrington KJ; Nutting CM; Schick U; Lau AS; Upile N; Sheard J; Brougham K; West CM; Oguejiofor K; Thomas S; Ness AR; Pring M; Thomas GJ; King EV; McCance DJ; James JA; Moran M; Sloan P; Shaw RJ; Evans M; Jones TM
Cancer Res; 2016 Nov; 76(22):6598-6606. PubMed ID: 27569214
[TBL] [Abstract][Full Text] [Related]
35. Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study.
Abajo M; Betriu À; Arroyo D; Gracia M; Del Pino MD; Martínez I; Valdivielso JM; Fernández E;
Nephrol Dial Transplant; 2017 Nov; 32(11):1882-1891. PubMed ID: 27566835
[TBL] [Abstract][Full Text] [Related]
36. Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial.
Strand V; Kremer JM; Gruben D; Krishnaswami S; Zwillich SH; Wallenstein GV
Arthritis Care Res (Hoboken); 2017 Apr; 69(4):592-598. PubMed ID: 27565000
[TBL] [Abstract][Full Text] [Related]
37. Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
Saag KG; Fitz-Patrick D; Kopicko J; Fung M; Bhakta N; Adler S; Storgard C; Baumgartner S; Becker MA
Arthritis Rheumatol; 2017 Jan; 69(1):203-212. PubMed ID: 27564409
[TBL] [Abstract][Full Text] [Related]
38. Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy.
Lahdensuo K; Erickson A; Saarinen I; Seikkula H; Lundin J; Lundin M; Nordling S; Bützow A; Vasarainen H; Boström PJ; Taimen P; Rannikko A; Mirtti T
Mod Pathol; 2016 Dec; 29(12):1565-1574. PubMed ID: 27562498
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 Study.
Franchi F; Rollini F; Aggarwal N; Hu J; Kureti M; Durairaj A; Duarte VE; Cho JR; Been L; Zenni MM; Bass TA; Angiolillo DJ
Circulation; 2016 Sep; 134(11):780-92. PubMed ID: 27559041
[TBL] [Abstract][Full Text] [Related]
40. Changes in the clinical presentation of patients with rheumatoid arthritis from the early 1990s to the years 2010: earlier identification but more severe patient reported outcomes.
Nieuwenhuis WP; de Wit MP; Boonen A; van der Helm-van Mil AH
Ann Rheum Dis; 2016 Nov; 75(11):2054-2056. PubMed ID: 27558985
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
